Corporate identity cues: The significance of the sales force

Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing

Volumn 1, Issue 1, 2000, Pages 9-19

  Dimopoulou, Eirini ^a   Fill, Chris ^b  

^a University of Portsmouth Business School ^*

^b UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

attributes; corporate image; identity cues; pharmaceutical; sales force

Indexed keywords

EID: 37449019578     PISSN: 17457904     EISSN: 17457912     Source Type: Journal    
DOI: 10.1057/palgrave.jmm.5040002     Document Type: Article

References (30)

1. Abratt R. Shee P. S. B. (1989) ‘A new approach to the corporate image management process’, Journal of Marketing Management, Vol. 5, No. 1 pp. 63–76.
2. Dubberley H. (1995) ‘Protecting corporate identity’, Communication Arts, Vol. 36 No. 8, January pp. 14–18.
3. Abratt Shee (1989) Communication Arts
4. Clarke J. (1997) ‘Management caution: A reputation can be hard to mend’, The Independent, 19 June.
5. Fombrun C. (1996) Reputation: Realising value through the corporate image, Harvard, Harvard Business School Press.
6. Corstjens M. (1991) Marketing Strategies in the Pharmaceutical Industry, London, Chapman & Hall.
7. Higgins R. B. Bannister B. D. (1992) ‘How corporate communication of strategy affects share price’, Long Range Planning, Vol. 25, No. 3 pp. 27–35.
8. Safian G. R. (1994) ‘Finding a new marketing mix for pharmaceuticals’, Public Relations Journal, Vol. 50, No. 3, March pp. 24–26.
9. Gebhart F. (1997) ‘Bang for the buck’, Drugs Topics, Vol. 141, No. 8, p. 40.
10. Huston P. (1993) ‘How physicians rate manufacturers: The top ten’, Medical Marketing and Media, Vol. 28, No. 1 pp. 28–35.
11. Holden P. (1992) Marketing Communications in the Pharmaceutical Industry, Oxford, Radcliff Professional Press.
12. Flynn B. H. Murray K. A. (1993) ‘Your sales force could be your weakness’, Journal of European Business, Vol. 5 No. 2, Nov/Dec pp. 45–48.
13. Smith M. C. (1994) Pharmaceutical Marketing: Strategy and Cases, Pharmaceutical Products Press.
14. Lexchin J. (1989) ‘Doctors and detailers: Therapeutic education or pharmaceutical promotion?’ International Journal of Health Studies, Vol. 19 No. 4 pp. 663–679.
15. Corstjens (1991) International Journal of Health Studies
16. Beardsley T. (1993) ‘Blood Money?’, Scientific American, August pp. 115–117.
17. Andaleeb S. S. Tallman R. F. (1996) ‘Relationships of physicians with pharmaceutical sales representatives and pharmaceutical companies: An exploratory study’, Health Marketing Quarterly, Vol. 13, No. 4 pp. 79–89.
18. Avorn J. Chen M. Hartley R. (1982) ‘Scientific versus commercial sources of influences on the prescribing behaviour of physicians’, The American Journal of Medicine, 73 July pp. 4–8.
19. Lexchin (1989) The American Journal of Medicine
20. Ziegler M. G. Lew P. Singer B. C. (1995) ‘The accuracy of drug information from sales representatives’, Journal American Medical Association, Vol. 273, No. 5, April pp. 1296–1298.
21. Lambert D. M. Marmorstein H. Sharma A. (1990) ‘Industrial salespeople as a source of market information’, Industrial Marketing Management, 19 pp. 141–148.
22. Swan J. E. Trawick F. I. Silva D. W. (1985) ‘How industrial sales people gain customer trust’, Industrial Marketing Management, 14 pp. 203–211.
23. Huston (1993) Industrial Marketing Management
24. Korschun A. (1992) ‘Why should I buy from you?’, American Salesman, Vol. 37, No. 8, August pp. 8–10.
25. Flynn Murray (1993) American Salesman
26. Hawes J. (1994) ‘To know me is to trust me’, Industrial Marketing Management, 23 pp. 215–219.
27. Flynn Murray (1993) Industrial Marketing Management.
28. Hayes M. H. Hartley S. W. (1989) ‘How Buyers view industrial salespeople’, Marketing Management, 18 pp. 73–80.
29. Hayes M. H. Hartley S. W. (1989) ‘How Buyers view industrial salespeople’, Marketing Management, 18 pp. 73–80.
30. Smith (1994) ‘How Buyers view industrial salespeople’, Marketing Management, 18 pp. 73–80.